1. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice;Benard;Cancer Res.,1985
2. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs;Brunner;Immunology,1968
3. Folate binding protein is a marker for ovarian cancer;Campbell;Cancer Res.,1991
4. Potent antibody therapeutics by design;Carter;Nat. Rev. Immunol.,2006
5. Fc receptors are required in passive and active immunity to melanoma;Clynes;Proc. Natl. Acad. Sci. U. S. A.,1998